Chinese Pharma Is on the Cusp of Going Global中国药业走向世界

After America， China is the world’s largest developer of new medicines. Its companies ran nearly a third of the planet’s clinical trials last year. That is up from just 5% a decade before. It is also rising to the top in several critical areas of research， including those related to cancer. Investors have taken note. Shares in Chinese biotech companies have surged by 110% this year， which is more than three times as much as their American peers.

继美国之后，中国已成为全球第二大新药研发国。（剩余7877字）